BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore

"Today's filing reinforces our ongoing commitment to delivering our COVID-19 vaccine, built on a proven, well-understood vaccine platform, to help end the ...

November 25, 2021 | News

Singapore Brand Buzud Launches Patented Oxygen Concentrator

A grand opening event was held yesterday at the retail store. Gracing the occasion with his presence was Dr Loo Choon Yong, executive chairman of Raffles M...

November 24, 2021 | News

Laos becomes the 20th country to authorize the one-shot Sputnik Light vaccine

Sputnik Light vaccine is based on human adenovirus serotype 26, which is the first component of the Sputnik V vaccine. In March 2021 the two-dose...

November 24, 2021 | News

How to Navigate Senior Care with added COVID Cautions

As if navigating senior care wasn't difficult enough, families around the world carry the weight of each decision they make for their loved one with the ad...

November 18, 2021 | Opinion

Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

November 23, 2021 | News

Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the Japanese government will purch...

November 11, 2021 | News

Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World

Applications Remain Under Review by Other Regulatory Authorities, Including U.S. Food and Drug Administration and the European Medicines Agency Merck (NYS...

November 08, 2021 | News

Novavax Files COVID-19 Vaccine for EU Listing with WHO

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

November 05, 2021 | News

Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe Novavax, Inc. (Nasdaq: NVAX), a biote...

November 04, 2021 | News

Novavax and Serum Institute of India Receive EUA for COVID-19 Vaccine in Indonesia

"The first authorization of Novavax' COVID-19 vaccine exemplifies our commitment to equitable global access and will fill a vital need for Indonesia, ...

November 02, 2021 | News

Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia

-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia --...

November 01, 2021 | News

Why is the WHO delaying an EUL status to Covaxin?

The World Health Organisation usually takes around 6 to 9 weeks to analyse the data submitted by a vaccine manufacturer and then takes a call on whether to...

October 30, 2021 | Opinion | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

Thermo Fisher Scientific Unveils first integrated digital PCR solution is ideal for oncology, cell and gene therapy development

Thermo Fisher Scientific, the world leader in serving science, today introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, ...

October 29, 2021 | News

Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity

Hanmi Science doesn't just want the world to know they are committed to vaccine equity, they want to prove it. Mr. Lim, CEO of Hanmi Science, echoes the co...

October 29, 2021 | News

Stay Connected